Compugroup Medical Se Stock Ten Year Return
| CMPVFDelisted Stock | USD 29.89 0.00 0.00% |
CompuGroup Medical SE fundamentals help investors to digest information that contributes to CompuGroup Medical's financial success or failures. It also enables traders to predict the movement of CompuGroup Pink Sheet. The fundamental analysis module provides a way to measure CompuGroup Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to CompuGroup Medical pink sheet.
CompuGroup |
CompuGroup Medical SE Company Ten Year Return Analysis
CompuGroup Medical's Ten Year Return shows the total annualized return generated from holding a fund for the last 10 years and represents fund's capital appreciation, including dividends losses and capital gains distributions. This return indicator is considered by many investors to be the ultimate measures of fund performance and can reflect the overall performance of the market or market segment it invests in.
More About Ten Year Return | All Equity Analysis
Ten Year Return | = | (Mean of Monthly Returns - 1) | X | 100% |
Although Ten Year Fund Return indicator can give a sense of overall fund long-term potential, it is recommended to compare funds performances against other similar funds or market benchmarks for the same 10-year interval.
CompetitionBased on the latest financial disclosure, CompuGroup Medical SE has a Ten Year Return of 0.0%. This indicator is about the same for the average (which is currently at 0.0) sector and about the same as Ten Year Return (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
CompuGroup Ten Year Return Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses CompuGroup Medical's direct or indirect competition against its Ten Year Return to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of CompuGroup Medical could also be used in its relative valuation, which is a method of valuing CompuGroup Medical by comparing valuation metrics of similar companies.CompuGroup Medical is currently under evaluation in ten year return category among related companies.
CompuGroup Fundamentals
| Return On Equity | 0.12 | |||
| Return On Asset | 0.033 | |||
| Profit Margin | 0.06 % | |||
| Operating Margin | 0.08 % | |||
| Current Valuation | 2.89 B | |||
| Shares Outstanding | 52.23 M | |||
| Shares Owned By Insiders | 50.30 % | |||
| Shares Owned By Institutions | 29.69 % | |||
| Price To Earning | 20.14 X | |||
| Price To Book | 2.49 X | |||
| Price To Sales | 1.97 X | |||
| Revenue | 1.03 B | |||
| Gross Profit | 411.46 M | |||
| EBITDA | 213.99 M | |||
| Net Income | 68.97 M | |||
| Cash And Equivalents | 120.07 M | |||
| Cash Per Share | 2.30 X | |||
| Total Debt | 587.08 M | |||
| Debt To Equity | 1.32 % | |||
| Current Ratio | 0.87 X | |||
| Book Value Per Share | 12.87 X | |||
| Cash Flow From Operations | 165.27 M | |||
| Earnings Per Share | 1.49 X | |||
| Number Of Employees | 8.83 K | |||
| Beta | 1.07 | |||
| Market Capitalization | 2.39 B | |||
| Total Asset | 1.79 B | |||
| Z Score | 2.4 | |||
| Annual Yield | 0.02 % | |||
| Net Asset | 1.79 B |
About CompuGroup Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze CompuGroup Medical SE's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CompuGroup Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CompuGroup Medical SE based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Other Consideration for investing in CompuGroup Pink Sheet
If you are still planning to invest in CompuGroup Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the CompuGroup Medical's history and understand the potential risks before investing.
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |